Study in Patients With COPD

Completed · Phase 2

Conditions studied: COPD, Chronic Obstructive Pulmonary Disease

In brief

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective for the treatment of COPD compared to the control drug

Key facts

Study ID

NCT00215423

Run by

Dey

People needed

49

Expected to finish

2005-09-01

Last updated by the study team

2010-11-11

Who can join

Age: 5 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of COPD
• History of cigarette smoking

You may not qualify if…

• Clinical diagnosis of asthma
• Significant pulmonary disease other than COPD
• Other significant major organ disease(s)

Where it is running

• Research Site — Phoenix, Arizona, United States
• Research Site — Wheat Ridge, Colorado, United States
• Research Site — Hines, Illinois, United States
• Research Site — Shawnee Mission, Kansas, United States
• Research Site — Butte, Montana, United States
• Research Site — Omaha, Nebraska, United States
• Research Site — Medford, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.